This clinical-stage biotechnology company is focused on the discovery and development of oral therapeutics for patients with autoimmune diseases. It uses an artificial intelligence based precision medicine platform to identify novel therapeutic targets based on predictions of immunometabolic function and create therapeutic candidates to engage those targets in areas of unmet medical need.